Updated:
Grandway Capital
Grandway Capital was established in 2015 in Shenzhen. It functions as the dedicated investment vehicle for Shenzhen Jiayuan Hengtong Investment Fund Co., LTD.
Grandway Capital
Grandway Capital was established in 2015 in Shenzhen. It functions as the dedicated investment vehicle for Shenzhen Jiayuan Hengtong Investment Fund Co., LTD. The firm pursues buyouts, early-stage venture, growth equity and PIPE opportunities. Asset classes include healthcare, information technology, consumer discretionary products and industrials. Geographic focus remains China with additional exposure to adjacent Asian markets. Confirmed strategy coverage includes seed, start-up, expansion and late-stage rounds. AUM stands at 307 million USD. No additional offices or headcount figures appear in available records. No dated operational events from the last 24 months are documented. The captive structure ties deployment directly to the parent fund's mandate without external LP commitments or separate fund vehicles.
General information
Firm type
Private Equity
Year founded
2015
AUM
307 (Altss estimate)
Location
Region
Asia
Country
China
City
Shenzhen
Corporate office
Shenzhen, Guangdong, China
Sector focus
Frequently asked questions
Who controls investment decisions at Grandway Capital?
Decisions sit with the captive team reporting to Shenzhen Jiayuan Hengtong Investment Fund Co., LTD. No individual principals are named in public records.
Does Grandway Capital commit to external funds or focus on direct deals?
The firm executes direct investments and co-investments within its stated strategies. No fund-of-funds activity is recorded.
Which investment stages receive the largest allocations?
Coverage spans seed through growth and buyout. Early-stage and expansion rounds appear most frequently in the strategy list.
What is the relationship between Grandway Capital and Shenzhen Jiayuan Hengtong?
Grandway Capital operates as the captive arm of Shenzhen Jiayuan Hengtong Investment Fund Co., LTD.
Which sectors does Grandway Capital explicitly target?
Healthcare, information technology, consumer discretionary and diversified industrials form the core focus.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: